Figure 3From: Cellular and humoral immune responses against the Plasmodium vivax MSP-119 malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of BrazilAnalysis of cellular activation by the expression of IL-2R after 96 h culture in presence of PvMSP-1 19 and PSS1 crude antigen by cytometry flow. (A) PBMC from malaria patients (n = 35) and control individuals (n = 17) and (B) PBMC from individuals infected with P. falciparum, P. vivax and control individuals. *p = 0.001 for PvMSP119 and p = 0.0003 for PSS1, malaria versus control individuals; ** p = 0.009 for P. falciparum versus controls and p = 0.003 for P. vivax versus controls; *** p = 0.004 for P. falciparum versus controls and p = 0.001 for P. vivax versus controls.Back to article page